| ||||||||
| ||||||||
| Site Group Page (References Reporting High Throughput Detection Method) |
| Site Information | ||||||||||||||||||||
|
||||||||||||||||||||
| References | ||
|
Wagner SA, et al. (2012) Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol Cell Proteomics 11, 1578-85
22790023 Curated Info |
|
|
Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44, 325-40
21906983 Curated Info |
|
|
Wagner SA, et al. (2011) A Proteome-wide, Quantitative Survey of In Vivo Ubiquitylation Sites Reveals Widespread Regulatory Roles. Mol Cell Proteomics 10, M111.013284
21890473 Curated Info |
|
|
Shi Y, et al. (2011) A data set of human endogenous protein ubiquitination sites. Mol Cell Proteomics 10, M110.002089
20972266 Curated Info |
|
|
Danielsen JM, et al. (2011) Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol Cell Proteomics 10, M110.003590
21139048 Curated Info |
|
|
(2010) CST Curation Set: 9189; Year: 2010; Biosample: AMO-1; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 9134; Year: 2010; Biosample: PY2; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2010) CST Curation Set: 9129; Year: 2010; Biosample: ES J1; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2010) CST Curation Set: 9133; Year: 2010; Biosample: P19; Disease: testicular cancer; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2010) CST Curation Set: 9131; Year: 2010; Biosample: NCCIT; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2010) CST Curation Set: 9132; Year: 2010; Biosample: NTERA-2; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8668; Year: 2009; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8669; Year: 2009; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8667; Year: 2009; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8663; Year: 2009; Biosample: KMS-27; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8657; Year: 2009; Biosample: KMS-12-BM; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8661; Year: 2009; Biosample: KMS-27; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8659; Year: 2009; Biosample: KMS-27; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8664; Year: 2009; Biosample: KMS-27; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8658; Year: 2009; Biosample: KMS-12-BM; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8662; Year: 2009; Biosample: KMS-27; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8646; Year: 2009; Biosample: U266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8653; Year: 2009; Biosample: KMS-12-BM; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8645; Year: 2009; Biosample: U266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8639; Year: 2009; Biosample: L363; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8160; Year: 2009; Biosample: mouse testis; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
Meierhofer D, Wang X, Huang L, Kaiser P (2008) Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. J Proteome Res 7, 4566-76
18781797 Curated Info |
|